CTKB
CTKB
US23285D1090
Cytek Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 201.493.000 200.453.000
0.5%
Cost of Revenue 97.033.000 89.347.000
8.6%
Gross Profit 104.460.000 111.106.000
6.0%
144.844.000 131.629.000
10.0%
Operating Income -40.384.000 -20.523.000
96.8%
Pretax Income -29.841.000 -5.700.000
423.5%
Net Income Common Stockholders -66.539.000 -6.020.000
1005.3%
-- --
--
-- --
--
ende